Sapient(@SapientBio) 's Twitter Profile Photo

๐–๐ž ๐š๐ซ๐ž ๐ญ๐ก๐ซ๐ข๐ฅ๐ฅ๐ž๐ ๐ญ๐จ ๐š๐ง๐ง๐จ๐ฎ๐ง๐œ๐ž ๐ญ๐ก๐š๐ญ ๐‰๐จ๐ง๐š๐ญ๐ก๐š๐ง ๐”๐ฌ๐ฎ๐ค๐š ๐ก๐š๐ฌ ๐ฃ๐จ๐ข๐ง๐ž๐ ๐ญ๐ก๐ž ๐’๐š๐ฉ๐ข๐ž๐ง๐ญ ๐ฅ๐ž๐š๐๐ž๐ซ๐ฌ๐ก๐ข๐ฉ ๐ญ๐ž๐š๐ฆ ๐š๐ฌ ๐‚๐ก๐ข๐ž๐Ÿ ๐๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐Ž๐Ÿ๐Ÿ๐ข๐œ๐ž๐ซ. Read the release: lnkd.in/e-_9ZJ5H

๐–๐ž ๐š๐ซ๐ž ๐ญ๐ก๐ซ๐ข๐ฅ๐ฅ๐ž๐ ๐ญ๐จ ๐š๐ง๐ง๐จ๐ฎ๐ง๐œ๐ž ๐ญ๐ก๐š๐ญ ๐‰๐จ๐ง๐š๐ญ๐ก๐š๐ง ๐”๐ฌ๐ฎ๐ค๐š ๐ก๐š๐ฌ ๐ฃ๐จ๐ข๐ง๐ž๐ ๐ญ๐ก๐ž ๐’๐š๐ฉ๐ข๐ž๐ง๐ญ ๐ฅ๐ž๐š๐๐ž๐ซ๐ฌ๐ก๐ข๐ฉ ๐ญ๐ž๐š๐ฆ ๐š๐ฌ ๐‚๐ก๐ข๐ž๐Ÿ ๐๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐Ž๐Ÿ๐Ÿ๐ข๐œ๐ž๐ซ. Read the release: lnkd.in/e-_9ZJ5H

#pharmanews #SapientTeam
account_circle
Pharma Manufacturing(@PharmaMfg) 's Twitter Profile Photo

Pfizer announced the sudden death of a participant in its phase 2 DAYLIGHT study, evaluating its new gene therapy for Duchenne muscular dystrophy (DMD) in pediatric patients.

Pfizer Inc.

pharmamanufacturing.com/development/clโ€ฆ

Pfizer announced the sudden death of a participant in its phase 2 DAYLIGHT study, evaluating its new gene therapy for Duchenne muscular dystrophy (DMD) in pediatric patients.

@pfizer #Pfizer #DMD #Pharmamanufacturing #pharmanews 

pharmamanufacturing.com/development/clโ€ฆ
account_circle
Pharma Industry Awards UK(@PharmaAwardsUK) 's Twitter Profile Photo

Does your company have what it takes to win at the Pharma Industry Awards UK 2024?

New categories added! โžก๏ธ Download the Entry Guide NOW to see if you qualify: landing.businessriver.com/Pharma-Industrโ€ฆ

Does your company have what it takes to win at the Pharma Industry Awards UK 2024?

New categories added! โžก๏ธ Download the Entry Guide NOW to see if you qualify: landing.businessriver.com/Pharma-Industrโ€ฆ

#PharmaIndustry #PharmaNews #PharmaUK
account_circle
PHARMAHUBNG(@pharmahub_NG) 's Twitter Profile Photo

โ—Oprelvekin

๐Ÿ”นMOA : (interleukin-11 [IL-11]) stimulates the growth of primitive megakaryocytic progenitors and increases the number of peripheral platelets

๐Ÿ”นIndication: Thrombocytopenia

๐Ÿ”น Dose : is 50 mcg/kg once daily.

โ—Oprelvekin

๐Ÿ”นMOA : (interleukin-11 [IL-11]) stimulates the growth of primitive megakaryocytic progenitors and increases the number of peripheral platelets

๐Ÿ”นIndication: Thrombocytopenia

๐Ÿ”น Dose : is 50 mcg/kg once daily.

#Pharmanews
account_circle
Pharma Industry Awards UK(@PharmaAwardsUK) 's Twitter Profile Photo

Is your work revolutionising healthcare? ๐ŸฉบShare your groundbreaking achievements and gain industry recognition.

Seek guidance with an award winning submission today! Download now for inspiration.

More: landing.businessriver.com/Pharma-Industrโ€ฆ

Is your work revolutionising healthcare? ๐ŸฉบShare your groundbreaking achievements and gain industry recognition.

Seek guidance with an award winning submission today! Download now for inspiration.

More: landing.businessriver.com/Pharma-Industrโ€ฆ

#PharmaIndustry #PharmaNews #PharmaUK
account_circle
NRx Pharmaceuticals(@NRxPharma) 's Twitter Profile Photo

NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update - Yahoo Finance

Read More - finance.yahoo.com/news/nrx-pharmโ€ฆ

$NRXP

account_circle
PHARMAHUBNG(@pharmahub_NG) 's Twitter Profile Photo

โ—Plerixafor Injection. It's intended for patients with non-Hodgkin's lymphoma or multiple myeloma

Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for plerixafor injection single-dose vial product.

โ—Plerixafor Injection. It's intended for patients with non-Hodgkin's lymphoma or multiple myeloma

Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for plerixafor injection single-dose vial product.

#Pharmanews
account_circle
NRx Pharmaceuticals(@NRxPharma) 's Twitter Profile Photo

NRx Pharmaceuticals today announced a statistically significant safety advantage of NRX-101 compared to the standard of care comparator in its recently completed clinical trial in patients with suicidal bipolar depression.

Read More - ir.nrxpharma.com/2024-05-06-NRxโ€ฆ

$NRXP

account_circle
PANS-UI ๐Ÿ(@UI_pharmacy) 's Twitter Profile Photo

1. Pharm. Babatunde Adebisi Ypg Oyo State Coordinator
2. SPECIAL APPRECIATION TO PHARMANEWS FOR BEING A BIG SUPPORT TOWARDS THE SUCCESS OF OUR PANS WEEK.
3. Editor-in-chief, PANS UI PRESS
4. BOND PHARMACEUTICALS were around also,we say a big THANK YOU FOR YOUR SUPPORT!

1. Pharm. Babatunde Adebisi Ypg Oyo State Coordinator
2. SPECIAL APPRECIATION TO PHARMANEWS FOR BEING A BIG SUPPORT TOWARDS THE SUCCESS OF OUR PANS WEEK.
3. Editor-in-chief, PANS UI PRESS
4. BOND PHARMACEUTICALS were around also,we say a big THANK YOU FOR YOUR SUPPORT!
account_circle
Pharma Manufacturing(@PharmaMfg) 's Twitter Profile Photo

The U.S. FDA hasย approved a new oral granules formulation of Neurocrine Biosciences' Ingrezza capsules to treat movement disorders (tardive dyskinesia) and chorea associated with Huntington's disease.

U.S. FDA Neurocrine Biosciences

pharmamanufacturing.com/development/drโ€ฆ

The U.S. FDA hasย approved a new oral granules formulation of Neurocrine Biosciences' Ingrezza capsules to treat movement disorders (tardive dyskinesia) and chorea associated with Huntington's disease.

@US_FDA @neurocrine #pharmamanufacturing #pharmanews

pharmamanufacturing.com/development/drโ€ฆ
account_circle
Republic Business(@RepublicBiz) 's Twitter Profile Photo

๐Ÿšจ | Despite a significant drop in COVID vaccine sales, Moderna's quarterly revenue exceeded expectations, hinting at a promising future for the pharma giant.
.
.
.
| | |

Read๐Ÿ‘‡๐Ÿผ
republicworld.com/business/interโ€ฆ

account_circle
NRx Pharmaceuticals(@NRxPharma) 's Twitter Profile Photo

Oral Antidepressants for Reduction in Suicidality Could Deliver New Standard of Care for Bipolar Depression
-US Healthcare Journal

ushealthcarejournal.com/article/707706โ€ฆ

$NRXP

account_circle